mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.7 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
0.025 |
0.7 |
mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
VU0155056 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |